Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 7/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | HTR2B | P41595 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | MEN1 | O00255 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.42 |
| ▸ | AR | P10275 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10741039 | 0.87 | MAPT (0.47) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL8938873 | 0.83 | MEN1 (0.39) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL3932390 | 0.83 | NPC1 (0.41) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL8727089 | 0.83 | MEN1 (0.38) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL8718097 | 0.83 | GAA (0.44) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL27969231 | 0.83 | MAPT (0.54) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL6418064 | 0.83 | HPGD (0.54) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL6414564 | 0.79 | ALDH1A1 (0.55) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL8722523 | 0.78 | TSHR (0.40) | HSD17B10ALDH1A1TDP1TSHRALOX12 | |
| SCHEMBL8721660 | 0.78 | ABCG2 (0.43) | ALDH1A1TSHRMAPTKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 543 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3778576-B1 | 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | HANLIM PHARMACEUTICAL CO LTD (KR) | 2024-04-17 | — | — | EP | claimed |
| CN-115400114-A | Application of non-steroidal organic selenium compound in preparation of medicine for treating or preventing intestinal inflammation related diseases | 辽宁大学 | 2022-11-29 | — | — | CN | claimed |
| US-20210047301-A1 | 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | HANLIM PHARMACEUTICAL CO., LTD. (KR) | 2021-02-18 | — | — | US | claimed |
| EP-3778576-A1 | 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | Hanlim Pharmaceutical Co., Ltd. (KR) | 2021-02-17 | — | — | EP | claimed |
| CN-111956639-A | Use of organic selenium compounds for treating diseases associated with neuroinflammation | 辽宁大学 | 2020-11-20 | — | — | CN | claimed |
| WO-2019190117-A1 | 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | 한림제약(주) | 2019-10-03 | — | — | WO | claimed |
| CN-110198927-A | Process for purifying N-substituted maleimides | 株式会社LG化学 | 2019-09-03 | — | — | CN | claimed |
| CN-110041272-A | 2- (2- chlorphenyl) quinazoline -4 (3H) -one analog derivative and its preparation method and application | 中国人民解放军军事科学院军事医学研究院 | 2019-07-23 | — | — | CN | claimed |
| CN-109880264-A | A kind of high-strength anti-flaming plastic-steel section bar based on organic-silicon-modified polyvinyl chloride | 湖南七纬科技有限公司 | 2019-06-14 | — | — | CN | claimed |
| CN-108138047-A | STABILIZER AND STABILIZATION METHOD | 和光纯药工业株式会社 | 2018-06-08 | — | — | CN | claimed |
| WO-2000076979-A1 | PYRIDINE CARBOXAMIDES AND THEIR USE AS PLANT PROTECTION AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2000-12-21 | — | — | WO | claimed |
| US-5952475-A | CATIONIC THIADIAZOLEDIPHENYLAMINE DYES FOR USE IN INKJET PRINTING AND IN LIGHT-WRITABLE DATA STORAGE MEDIA AND IN DYE TRANSFER FILMS | BAYER AKTIENGESELLSCHAFT (DE) | 1999-09-14 | — | — | US | claimed |
| EP-0884367-A2 | Cationic diphenylamine dyestuffs and their anhydrobases | BAYER AG (DE) | 1998-12-16 | — | — | EP | claimed |
| EP-0757083-A2 | Cationic thiazolazo and benzothiazolazo dyestuffs | Ciba SC Holding AG (CH) | 1997-02-05 | — | — | EP | claimed |
| EP-0377358-A2 | Nitrogen-bearing additives having antioxidant properties, and lubricant compositions comprising same | ELF ANTAR FRANCE (FR) | 1990-07-11 | — | — | EP | claimed |
| US-4874849-A | FOR DYEING WOOL, POLYAMIDES, LEATHER ORANGE OR BROWN | CIBA-GEIGY CORPORATION (US) | 1989-10-17 | — | — | US | claimed |
| US-4161534-A | ANTHELMINTICS | CIBA-GEIGY CORPORATION (US) | 1979-07-17 | — | — | US | claimed |
| US-4064265-A | ANTHELMINTICS | CIBA-GEIGY CORPORATION (US) | 1977-12-20 | — | — | US | claimed |
| US-4048153-A | Azo dyes having an optionally substituted 1-azo-3-nitro-4-arylaminophenyl nucleus | SANDOZ LTD. (CH) | 1977-09-13 | — | — | US | claimed |
| US-4018611-A | Non-yellowing antimicrobial compositions comprising diiodomethyl sulfones | METALORGANA ETABLISSEMENT (FL) | 1977-04-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210047301-A1 | 2-CYANOPYRIMIDIN-4-YL CARBAMATE OR UREA DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME | CTSK, CTSS, CTSZ | HSD17B10 3057/4885ALDH1A1 4627/4885TDP1 3779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.